Frazer Coutinho obtained his Bachelor’s degree in Biomedical Science and Master’s degree in Science majoring in Microbiology and Immunology from the University of Otago. He has been a PhD student within the Buchanan Ocular Therapeutics Unit, University of Auckland, since 2015, investigating the therapeutic potential of XG19 in ocular disease. He has a passion for innovation and is particularly interested in translational science, taking therapeutics from bench to bedside.